Author Archives: Gabriel Silverman

Picking A PCSK9

Liphorus Pharmaceuticals announces financing of $6.4 million to support development of small molecules inhibitors targeting PCSK9 for the treatment of hypercholesterolemia

Creation of Liphorus Pharmaceuticals A significant investment in healthcare in Montréal